U.S. flag

An official website of the United States government

GTR Home > Conditions/Phenotypes > Coenzyme Q10 deficiency, primary, 1

Coenzyme Q10 deficiency, primary, 1

Synonyms
APTX-Related Coenzyme Q10 Deficiency; COENZYME Q DEFICIENCY 1; COQ2-Related Coenzyme Q10 Deficiency; CoQ DEFICIENCY 1; UBIQUINONE DEFICIENCY 1

Summary

Primary coenzyme Q10 (CoQ10) deficiency is usually associated with multisystem involvement, including neurologic manifestations such as fatal neonatal encephalopathy with hypotonia; a late-onset slowly progressive multiple-system atrophy-like phenotype (neurodegeneration with autonomic failure and various combinations of parkinsonism and cerebellar ataxia, and pyramidal dysfunction); and dystonia, spasticity, seizures, and intellectual disability. Steroid-resistant nephrotic syndrome (SRNS), the hallmark renal manifestation, is often the initial manifestation either as isolated renal involvement that progresses to end-stage renal disease (ESRD), or associated with encephalopathy (seizures, stroke-like episodes, severe neurologic impairment) resulting in early death. Hypertrophic cardiomyopathy (HCM), retinopathy or optic atrophy, and sensorineural hearing loss can also be seen. [from GeneReviews]

Available tests

69 tests are in the database for this condition.

Clinical tests (69 available)

Molecular Genetics Tests

Genes See tests for all associated and related genes

  • Also known as: CL640, COQ10D1, MSA1, PHB:PPT, COQ2
    Summary: coenzyme Q2, polyprenyltransferase

Clinical features

Help
Imported from Human Phenotype Ontology (HPO)

Show allHide all

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.